While little progress was made this year to lower overall drug costs, some changes made by the Bipartisan Budget Act (BBA) of 2018 are helping an estimated 5 million Medicare beneficiaries with the highest annual out-of- ...

Leslie R.’s biggest problem isn’t the fact that she’s 70, or that she’s trying to live on just Social Security and a small pension.  Leslie is a type II insulin dependent diabetic, left with no savings after a battle wit ...

By Mary Johnson, editor If you have an inflammatory disease like a chronic pulmonary condition, cardiovascular disease, diabetes, inflammatory bowel disease (IBS), or even sleep apnea, I have one piece of advice:  Go ...

The largest share of participants in TSCL’s 2018 Senior Survey, 43%, say that medical expenses were their fastest rising cost in 2017.  Just medications alone take about 12.6% of the budgets of Americans age 65 and over, ...

By Mary Johnson, editor Your Part D drug plan would never tell you this, but the alarming fact is that there is no limit to what you might spend out-of-pocket for your prescriptions drugs in any given year.  While t ...

Despite Support, No Bill Moving On Medicare Drug Price Negotiations Ninety percent of the people participating in TSCL’s 2017 Senior Survey support giving Medicare the power to negotiate lower drug prices. But so far ...

Drug Rebates Often Not Going To Patients A behind-the-scene rebate game between drug makers, health insurers and their pharmacy benefit managers is costing you and the Medicare program in higher drug costs.  A researc ...

Sudden price spikes in older drugs are putting patients at risk of going without vital medicine.  A new report by the U.S. Senate Special Committee on Aging uncovered an insidious business model that’s leading to monopol ...

What a New Congress Means For Medicare TSCL is closely following proposals that would overhaul Medicare as a part of the plans to repeal the 2010 Affordable Care Act.  House Speaker Paul Ryan (WI) has put forward a pl ...